Sort
35,931 grants matching “parkinsons”
NEUROPROSTHETIC MANAGEMENT OF ORTHOSTATIC HYPOTENSION IN PARKINSON'S DISEASE
$1,499,843Ecole Polytechnique Federale De Lausanne, Epfl · · FY2024 · Defense Health Agency
Neuropathology of CTE and Delayed Effects of TBI: Toward In-Vivo Diagnostics
$1,499,710Wayne A Gordon · Icahn School Of Medicine At Mount Sinai · U01 · FY2016 · NS
GENES, ENVIRONMENT, AND PRODROMAL FEATURES OF PARKINSON DISEASE
$1,499,649President And Fellows Of Harvard College · · FY2020 · Defense Health Agency
GENETIC AND ENVIRONMENTAL INFLUENCES ON THE PATHOGENESIS OF PARKINSON'S DISEASE: YOUNG ADULT BRAIN AND BEHAVIORAL RISK INDICA.
$1,499,570The Trustees Of Columbia University In The City Of New York · · FY2019 · Defense Health Agency
EFFECTS OF EXERCISE ON GLYMPHATIC FUNCTIONING AND NEUROBEHAVIORAL CORRELATES IN PARKINSON'S DISEASE. NEW AWARD.
$1,499,172Vanderbilt University Medical Center · · FY2019 · Defense Health Agency
Investigating the neural mechanisms of human cognitive function through intracranial recordings
$1,498,969Kareem Zaghloul · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
A National Resource for Postmortem Brain Research
$1,498,782Francine M. Benes · Mclean Hospital · R24 · FY2010 · MH
Mechanistic Analyses of kinase signaling complexes
$1,498,095Ping Zhang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Mechanisms of molecular machines that regulate the neuronal cytoskeleton
$1,497,271Antonina Roll-Mecak · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
THE ROLE OF ASTROCYTES AND MICROGLIA IN EXERCISE-INDUCED NEUROPLASTICITY IN PARKINSON'S DISEASE.
$1,496,538University Of Southern California · · FY2019 · Defense Health Agency
Targeted Neuroprotection for HIV-1 Associated Dementia
$1,496,456University Of Rochester · P01 · FY2003 · MH
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
$1,496,347Daniel Woo · University Of Cincinnati · U01 · FY2016 · NS
Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
$1,496,223Ali R Rezai · West Virginia University · UH3 · FY2024 · DA
Pacific Udall Center
$1,495,767Thomas J Montine · Stanford University · P50 · FY2019 · NS
Biomarkers of Catecholaminergic Neurodegeneration
$1,495,643David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Biomarkers of Catecholaminergic Neurodegeneration
$1,495,263David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
GENE THERAPY IN A NONHUMAN PRIMATE MODEL OF COGNITIVE DEFECTS IN PARKINSON'S DISEASE
$1,493,233The Trustees Of Columbia University In The City Of New York · · FY2024 · Defense Health Agency
Molecular Chaperones and DNA Replication
$1,492,861Sue H Wickner · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Pathologic protein folding and human disease
$1,492,273David B. Teplow · University Of California Los Angeles · P01 · FY2007 · AG
INCREASING NIGRAL TYROSINE HYDROXYLASE EXPRESSION AS A MECHANISM OF EXERCISE-MEDIATED RECOVERY: EVALUATION IN TOXIN AND RAT PARKINSON'S DISEASE GENETIC MODELS
$1,491,860The University Of North Texas Health Science Center At Fort Worth · · FY2019 · Defense Health Agency
Detection of Prions
$1,491,280Byron Caughey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
National Brain and Tissue Resource for Parkinson's Disease and Related Disorders
$1,488,864Thomas G Beach · Banner Sun Health Research Institute · U24 · FY2013 · NS
CNS sirtuins in radiation-induced vascular permeability and neurodegeneration
$1,488,434Deedee Smart · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Coenzyme Q10 in Huntington's Disease
$1,487,896Merit E Cudkowicz · Massachusetts General Hospital · R01 · FY2007 · NS
Functional Organization Of The Basal Ganglia
$1,487,577Charles R Gerfen · National Institute Of Mental Health · ZIA · FY2013 · MH